Obesity modifies prostatic specific antigen in men over 45 years

Archivos Espanoles de Urologia

Volumn 64, Issue 1, 2011, Pages 35-42

  Fontana, Constanza Lopez ^a   Maselli, Maria Eugenia ^a   Elizalde, Rafael Perez ^a,b   Di Milta, Nicolas ^a   Alberto, Pablo Corica ^c   Laur, Jose Daniel Lopez ^a,d  

^a Universidad Juan Agustin Maza   (Argentina)

^b Laboratorio de Alta Complejidad Pérez Elizalde   (Argentina)

^c Hospital Cristo Redentor   (Puerto Rico)

^d UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

Author keywords

Body mass index; Obesity; Plasma hemodilution; Prostate cancer screening; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

AGED; ANTHROPOMETRY; ARGENTINA; ARTICLE; BLOOD; BODY MASS; FEMALE; HEMODILUTION; HUMAN; METABOLISM; MIDDLE AGED; OBESITY; PUERTO RICO;

AGED; ANTHROPOMETRY; ARGENTINA; BODY MASS INDEX; FEMALE; HEMODILUTION; HUMANS; MIDDLE AGED; OBESITY; PROSTATE-SPECIFIC ANTIGEN; PUERTO RICO; TESTOSTERONE;

EID: 79551563671     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. López Laur JD. Manual de Urología Moderna. Editorial Atlante, 2005.
2. Bañez LL, Hamilton RJ, Partin AW, Sun L, Rodriguez C, Wang Y et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007, 298:2275-2280. (Pubitemid 350146217)
3. Consenso Nacional Inter-Sociedades sobre pautas para el Diagnóstico y Tratamiento de Cáncer de Próstata. Ministerio de Salud y Ambiente de la Nación. 2008.
4. World Health Organization. 1998. Obesity. Preventing and Managing the global epidemia. Report no 794. WHO, Geneva.
5. López Laur JD, Pérez Elizalde RF, Di Milta N, Maselli ME, Vanrel MC, Recalde GM et al. Effect of hemodilution on prostatic specific antigen in obese men. J Urol 2009, 181: S652. #1806.
6. Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee. World Health Organ Teach Rep Ser. 1995, 854:1-452.
7. Das UN. Is obesity an inflammatory condition? Nutrition 2001, 17:953-966.
8. Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007, 86: s843-57.
9. Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007, 29:88-97.
10. Mistry T, Digby J, Desai K, Randeva H. Obesity and Prostate Cancer: A role for Adipokines. European Association of Urology 2007, 52:46-53.
11. López Fontana C, Di Milta N, Maselli ME, Recalde GM, Vanrell MC, Pérez Elizalde R et al. The rol of leptin and adiponectin on prostate cancer. Arch Esp Urol 2009, 62 (2):103-8.
12. Han JH, Choi NY, Bang SH, Kwon OJ, Jin YW, Myung SC et al. Relationship Between Serum Protate-Specific Antigen Levels and Components of Metabolic Syndrome and Healthy Men. Urology 2008, 72 (4):749-54.
13. Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL et al. Obesity and Oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases. BJU Int 2008, 102:969-74.
14. Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ. Body mass index, prostatespecific antigen and digital rectal examination findings among participants in a prostate cancer screening clinic. Urology 2008, 71:787-91.
15. Freedland SJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Trock B et al. Search Database Study Group. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 2004, 172:520-4.
16. Larré S, Azzouzi AR, Cancel-Tassin G, Cormier L, Villette JM, Hoffman P et al. Impact of obesity on PSA in prostate cancer screening. Prog Urol. 2007, 17:815-8.
17. Baillargeon J, Polloxk BH, Kristal AR, Bradshaw P, Hernandez J, Basler J et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005, 103:1092-5.
18. Werny DM, Thompson T, Saraiya M, Freedman D, Kottiri BJ, German RR et al. Obesity is negatively associated with prostate-specific antigen in U. S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev. 2007, 16:70-6.
19. Goldstraw MA, Besrani D, Amoroso P, Kirby RS. Is obesity a risk factor for prostate cancer?. BJU int 2007;726-728.
20. Frankenberry KA, Somasundar P, Mc Fadden DW, Vona-Davis LC. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg 2004;188:560-5.
21. Carroll P, Albertsen P, Greene K, Barbaian R. PSA best practice statment 2009: Update. AUA Guidelines.
22. Heidenreich A, Bolla M, Jovian S. Guidelines on prostate cancer EAU editions: 1-138. 2009.
23. Ohwaki K, Endo F, Muraishi O, Hiramatsu S, Yano E. Relationship between Prostate-specific antigen and Hematocrit: Does hemodilution lead to lower PSA concentrations in men with a higher body mass index? Urology 2010, 75:648-52.